CXCR2 antibodies target tumors and neutrophils, enhancing immunotherapy in ARID1A-deficient pancreatic cancer
Pancreatic cancer has long been regarded as one of the most difficult cancers to treat, not only because malignant cells ...
Pancreatic cancer has long been regarded as one of the most difficult cancers to treat, not only because malignant cells ...
In a groundbreaking study published recently, researchers have unveiled the intricate and powerful interplay between ferroptosis and immunotherapy in the ...
In the unrelenting battle against pancreatic cancer, a malignancy notorious for its dismal prognosis and resistance to conventional therapies, a ...
In recent years, the landscape of cancer treatment has been dramatically transformed by the advent of immune checkpoint inhibitors (ICIs), ...
In the ever-evolving field of cancer research, recent studies have unveiled critical insights into the mechanisms underlying immunotherapy resistance, particularly ...
High levels of fat mass and obesity-associated protein, commonly known as FTO, are increasingly recognized for their role in promoting ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine